January, 2006
For the five preventive conditions examined (including two types of cancer screening), it was determined that the provision of increased access to NEMT for the transportation-disadvantaged population is cost-effective for all five, because projected improvements in life expectancy and quality of life are large enough to justify the net cost increases.
January, 2006
For the five preventive conditions examined, the results show a net cost saving, whereas for the other four, improvements in life expectancy or quality of life are sufficient to justify the added expense.
January, 2006
Adding relatively small transportation costs to an otherwise disease-specific, cost-effective environment does not make improved access to care non-cost-effective. For example, a congestive heart failure monitoring program that is already evaluated as highly cost-effective will not transition to cost-ineffective because of the addition of only incremental transportation costs.
January, 2006
Authors find that the provision of NEMT to those who currently lack it results in a net cost savings across the transportation and health care domains for four of these conditions (prenatal care, asthma, heart disease, and diabetes) and is cost-effective for the remaining eight conditions (influenza vaccinations, breast cancer screening, colorectal cancer screening, dental […]
January, 2005
Studies from Kentucky, Georgia, Connecticut, and North Carolina have shown that factors such as computer-aided scheduling and tight controls on eligibility can increase the capacity of available service by reducing average trip length, transporting multiple passengers simultaneously, and reducing the number of ineligible trips. In that way, average trip cost is reduced and more trips […]